Behzad Mahdavi
Chief Executive Officer bei TIM BV
Profil
Behzad Mahdavi is currently the Chief Executive Officer & Director at TIM BV since 2023.
Prior to this, he worked as the Vice President-Global Open Innovation at Catalent Pharma Solutions, Inc. and as the Senior Vice President-Life Sciences Tools at Ginkgo Bioworks Holdings, Inc. Mr. Mahdavi holds a doctorate from the University of Sherbrooke and an MBA from the University of Quebec.
Aktive Positionen von Behzad Mahdavi
| Unternehmen | Position | Beginn |
|---|---|---|
TIM BV
 TIM BV Miscellaneous Commercial ServicesCommercial Services TIM BV is a Dutch research company that specializes in performance evaluation of oral drugs. The company is based in Delft, Netherlands. The company leverages their proprietary and bio-predictive in vitro technology to support decision-making during oral drug development, which helps to de-risk the development trajectory. The CEO of the company is Robert-Jan Raterink. | Chief Executive Officer | 28.11.2023 |
Ehemalige bekannte Positionen von Behzad Mahdavi
| Unternehmen | Position | Ende |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Corporate Officer/Principal | - |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Ausbildung von Behzad Mahdavi
| University of Sherbrooke | Doctorate Degree |
| University of Quebec | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Health Services |
| Private Unternehmen | 2 |
|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
TIM BV
TIM BV Miscellaneous Commercial ServicesCommercial Services TIM BV is a Dutch research company that specializes in performance evaluation of oral drugs. The company is based in Delft, Netherlands. The company leverages their proprietary and bio-predictive in vitro technology to support decision-making during oral drug development, which helps to de-risk the development trajectory. The CEO of the company is Robert-Jan Raterink. | Commercial Services |
